Primary Embryonal Carcinoma of the Retroperitoneum

Nobuyuki Ohkubo, Tohru Ogihara, Toshihiro Miura, Kenzo Soejima, Shigeru Iyori, Yoshikiyo Akasaka, Masao Tashiro

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A 32-year-old man with primary embryonal carcinoma of the retro peritoneum, a very rare condition, is reported. The disease took an acute course with rapid enlargement of cervical and inguinal lymph nodes, and high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) values were observed. His testes were, however, intact. Remarkable tumor regression was achieved by systemic combination chemotherapy with cisplatin, vin lastine, and bleomycin (PVB therapy). This chemotherapy is beneficial even in advanced cases. In the two years since therapy, no recurrence has been observed. (Internal Medicine 32: 295-297, 1993).

Original languageEnglish
Pages (from-to)295-297
Number of pages3
JournalInternal Medicine
Volume32
Issue number4
DOIs
Publication statusPublished - 1993 Jan 1

Keywords

  • PVB therapy
  • alpha-fetoprotein
  • cisplatin
  • extragonadal
  • germ cell tumor
  • human chorionic gonadotropin

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Primary Embryonal Carcinoma of the Retroperitoneum'. Together they form a unique fingerprint.

  • Cite this

    Ohkubo, N., Ogihara, T., Miura, T., Soejima, K., Iyori, S., Akasaka, Y., & Tashiro, M. (1993). Primary Embryonal Carcinoma of the Retroperitoneum. Internal Medicine, 32(4), 295-297. https://doi.org/10.2169/internalmedicine.32.295